Ergoteles’s Avalon GloboCare ALBT Stock Holding History

Ergoteles’s Portfolio ALBT Stock Details ALBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-579	Closed	-$77K	–	1210
2021 Q3	$77K	Buy	579 +180	+45%	+$26.1K	﹤0.01%	1119
2021 Q2	$59K	Buy	+399	New	+$63.6K	﹤0.01%	1438

Other funds holding ALBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GAG

GM Advisory Group Melville, New York $2.6B AUM 18.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ergoteles's ALBT Position: Q4 2021 in Review

Ergoteles sold out of Avalon GloboCare (ALBT) in Q4 2021, closing a stake of 579 shares — an estimated $77K sold.

Ergoteles first reported a position in ALBT in Q2 2021 and held it in 2 quarters. The position peaked at $77K in Q3 2021. 16 funds tracked by Wall St. Rank hold ALBT as of Q4 2021.

Ergoteles reported no remaining Avalon GloboCare position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 579 Avalon GloboCare shares in Q4 2021, an estimated $77K.
Ergoteles first reported a position in Avalon GloboCare in Q2 2021 and held it in 2 quarters.
Ergoteles's Avalon GloboCare position peaked at $77K in Q3 2021.
16 funds tracked by Wall St. Rank held Avalon GloboCare as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.